Question 1

What is the safest ibogaine clinic?

Accepted Answer

The safest ibogaine clinic is one that is government-licensed, staffed by on-site physicians, performs full cardiac screening (EKG and echocardiogram) before dosing, monitors patients 24/7 during ceremony, and maintains documented emergency protocols. Sanctuary Tulum meets all of these standards, operates under a federal health license, and has maintained a perfect safety record across thousands of sessions since 2011.

Question 2

How do I know if a psychedelic facility is medically safe?

Accepted Answer

Ask for the facility's government license number, verify it with the issuing authority, confirm physicians are on-site (not on-call), request their pre-treatment medical screening protocol, and ask how many years they have operated. A safe facility will provide all of this in writing without hesitation.

Question 3

What safety protocols should an ayahuasca retreat have?

Accepted Answer

A safe ayahuasca retreat should include medical intake screening, review of all medications and cardiovascular history, on-site medical staff during ceremony, emergency response protocols, contraindication screening for SSRIs and MAOIs, and integration support after ceremony. Sanctuary Tulum provides all of these under full medical supervision.

Question 4

Is Sanctuary Tulum licensed?

Accepted Answer

Yes. Sanctuary Tulum operates under a Federal License of Operation for Hospital and Clinic issued by Mexico’s federal health authority. This is a full medical facility license, not a wellness or spa registration.

Question 5

How long has Sanctuary Tulum operated safely?

Accepted Answer

Sanctuary Tulum has operated continuously since 2011 — over 15 years — and has maintained a perfect safety record across thousands of medically supervised plant medicine sessions. Every treatment is preceded by comprehensive medical screening and delivered under physician oversight.

Question 6

Why does cardiac screening matter before ibogaine?

Accepted Answer

Ibogaine can prolong the QT interval on an EKG, which in rare cases can trigger dangerous heart rhythms in susceptible patients. Pre-treatment EKG and echocardiogram screening identify at-risk patients so ibogaine is only administered to those who are medically appropriate. Skipping this screening is the single largest safety risk in the industry.